Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
France
Centre Hospitalier Lyon Sud, Pierre-Bénite, Pierre Bénite Institut Bergonié, Bordeaux Centre François Baclesse, Caen Centre Oscar Lambret, Lille Institut Paoli-Calmettes, Marseille Centre Antoine Lacassagne, Nice Assistance Publique Hôpitaux de Paris, Paris Centre Eugène Marquis, Rennes Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse Age range
18 Years and older
Last updated February 2024